Skip to main content

Benefits of high-dose vitamin C for ovarian cancer patients


Benefits of high-dose vitamin C for ovarian cancer patients


Scientists at the University of Kansas Medical Center have determined that high doses of vitamin C, administered intravenously with traditional chemotherapy, helped kill cancer cells while reducing the toxic effects of chemotherapy for some cancer patients.
Image result for vitaminsBy evaluating the therapy in cells, animals, and humans, the researchers found that a combination of infused vitamin C and the conventional chemotherapy drugs carboplatin and paclitaxel stopped ovarian cancer in the laboratory, and reduced chemotherapy-associated toxicity in patients with ovarian cancer. The results of their study have been published in the journal Science Translational Medicine.
"In the 1970s, ascorbate, or vitamin C, was an unorthodox therapy for cancer. It was safe, and there were anecdotal reports of its clinical effectiveness when given intravenously. But after oral doses proved ineffective in two cancer clinical trials, conventional oncologists abandoned the idea. Physicians practicing complementary and alternative medicine continued to use it, so we felt further study was in order," explains the study's senior author, Qi Chen, Ph.D., Assistant Professor in KU Medical Center's Department of Pharmacology, Toxicology and Therapeutics and the Department of Integrative Medicine. "What we've discovered is that, because of its pharmacokinetic differences, intravenous vitamin C, as opposed to oral vitamin C, kills some cancer cells without harming normal tissues."
The researchers' clinical trial involved 27 patients with newly diagnosed Stage 3 or Stage 4 ovarian cancer. All of the participants received conventional therapy with paclitaxel or carboplatin, while some were also treated with high-dose intravenous vitamin C. Researchers monitored the participants for five years. Those patients who received vitamin C tended to experience fewer toxic effects from the chemotherapy drugs.
In laboratory rodents, the scientists observed that vitamin C was able to kill cancer cells at the concentrations achievable only by intravenous infusion, with no observable toxicity or pathological changes in the liver, kidney or spleen.
Collaborating on the study at KU Medical Center were postdoctoral fellow Yan Ma and graduate student Kishore Polireddy in the Department of Pharmacology, Toxicology and Therapeutics; Jeanne Drisko, M.D., director of the Integrative Medicine program; and Julia Chapman, M.D., associate professor in the Department of Obstetrics and Gynecology. Collaborating with the team was Mark Levine, M.D., at the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health.
High-dose vitamin C is currently administered intravenously to thousands of patients by practitioners of complementary and alternative medicine. However, Drisko notes, conventional physicians remain skeptical about its therapeutic benefits. Given this current polarization of thought, the researchers sought to understand the cellular mechanisms by which pharmacologic vitamin C manifests its therapeutic benefit in cancer.
"We aimed to investigate the mechanisms of vitamin C-induced cell death in the laboratory. And in patients with ovarian cancer, we conducted an early phase clinical trial examining safety and toxicity of high dose intravenous vitamin C. We now have a better understanding of vitamin C's anti-cancer action, plus a clear safety profile, and biological and clinical plausibility with a firm foundation to proceed," Drisko says. "Taken together, our data provide strong evidence to justify larger and robust clinical trials to definitively examine the benefit of adding vitamin C to conventional chemotherapy."

Story Source:
Materials provided by University of Kansas Cancer CenterNote: Content may be edited for style and length.

Journal Reference:
  1. Y. Ma, J. Chapman, M. Levine, K. Polireddy, J. Drisko, Q. Chen. High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of ChemotherapyScience Translational Medicine, 2014; 6 (222): 222ra18 DOI: 10.1126/scitranslmed.3007154

Comments

Popular posts from this blog

Essential Minerals

Minerals: Functions and Sources The body needs many minerals; these are called essential minerals . Essential minerals are sometimes divided up into major minerals (macrominerals) and trace minerals (microminerals).  A balanced diet usually provides all of the essential minerals. The two tables below list minerals, what they do in the body (their functions), and their sources. Major minerals Mineral Function Sources Sodium Needed for proper fluid balance, nerve transmission, and muscle contraction Table salt, soy sauce; large amounts in processed foods; small amounts in milk, breads, vegetables, and unprocessed meats Chloride Needed for proper fluid balance, stomach acid Table salt, soy sauce; large amounts in processed foods; small amounts in milk, meats, breads, and vegetables Potassium Needed for proper fluid balance, nerve transmission, and muscle contraction Meats, milk, fresh fruits and vegetables, whole grains, legumes Calciu...

Vitamin C Can Reduce High Blood Pressure, Study Finds

Vitamin C Can Reduce High Blood Pressure, Study Finds CORVALLIS, Ore. - Researchers have discovered that a 500 milligram daily supplement of vitamin C can significantly reduce high blood pressure in hypertensive patients. The study, published this month in the medical journal Lancet, was done by scientists at the Boston University School of Medicine and the Linus Pauling Institute at Oregon State University. It was supported by the National Heart, Lung and Blood Institute of the National Institutes of Health. "Hypertension is a serious health problem in much of the world," said Balz Frei, professor and director of the Linus Pauling Institute, and a co-author of the research along with principal investigator Dr. Joseph Vita at Boston University. "It's a key risk factor in heart disease and strokes." "We believe this is a significant finding that may be of considerable value to patients who have moderately elevated blood pressure," Frei s...

Zinc can halt the growth of cancer cells, study says

Zinc can halt the growth of cancer cells, study says Zinc supplements can significantly inhibit the proliferation of esophageal cancer cells, according to a new study co-authored by a University of Texas at Arlington researcher. Previous studies had shown that zinc is essential for maintaining human health and protects the esophagus from cancer. However, it has never been fully understood why zinc has the ability to prevent cancer in the esophagus. In this study, a team led by Zui Pan, an associate professor of nursing at UTA's College of Nursing and Health Innovation and a noted esophageal cancer researcher, discovered that zinc selectively halts the growth of cancer cells but not normal esophageal epithelial cells. The finding was published this month in  The FASEB Journal , the official journal of the Federation of American Societies for Experimental Biology. Esophageal cancer is the sixth leading cause of human cancer deaths around the world, according to the Nation...